findmyKOL
Clinical trialNCT05969041RecruitingPhase 1Interventional

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

SponsorMyeloid TherapeuticsEnrollment48Epithelial Tumors, Malignant
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • St Vincent'S Public Hospital Sydney

    Darlinghurst, New South Wales, Australia

    Recruiting
  • Scientia Clinical Research Ltd

    Randwick, New South Wales, Australia

    Charlotte Lemech, MD
    Recruiting
  • Westmead Hospital

    Westmead, New South Wales, Australia

    Adnan Nagrial, MD
    Recruiting
  • Souther Oncology Clinical Research Unit (socru)

    Bedford Park, South Australia, Australia

    Recruiting
  • Cabrini Health

    Malvern, Victoria, Australia

    Gary Richardson, MD
    Recruiting
  • Linear Clinical Research Ltd

    Nedlands, Western Australia, Australia

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Aug 2023
Primary completion
31 Aug 2027
Completion
31 Aug 2028
Last update posted
18 Jan 2024
Registered enrollment
48
Registry id
NCT05969041

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.